Burney Co/ »

Travere Therapeutics shares owned by Burney Co/

Quarter-by-quarter ownership of Travere Therapeutics (TVTX) shares owned by Burney Co/ from 13F filings

Historical chart of Burney Co/ investment in Travere Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Travere Therapeutics held by Burney Co/ consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Travere Therapeutics by Burney Co/

Quarter filed Position value Share count Share price at filing
2026-03-31 $1.2M 40k 29.71

More positions owned by Burney Co/

Ea Series Trust Burney Us Eqty
Ea Series Trust Burney Us Fctr (BRNY)
Apple (AAPL)
Vanguard Scottsdale Fds Inter Term Treas (VGIT)
Alphabet Cap Stk Cl A (GOOGL)
NVIDIA Corporation (NVDA)
Lam Research Corp Com New (LRCX)
Meta Platforms Cl A (META)
Parker-Hannifin Corporation (PH)
Dimensional Etf Trust Intl Core Equity (DFIC)
McKesson Corporation (MCK)
Broadcom (AVGO)
Microsoft Corporation (MSFT)
Arista Networks Com Shs (ANET)
Expedia Group Com New (EXPE)

View all positions for Burney Co/

Top funds holding Travere Therapeutics

Henderson Group
FMR
BlackRock
Vanguard Group
Armistice Capital
State Street Corporation
Perceptive Advisors
Vanguard Capital Management
Nomura Asset Management International
Adage Capital Partners GP
Kynam Capital Management
Geode Capital Management
Renaissance Technologies
Stephens Investment Management Group
Goldman Sachs Group

View all funds holding Travere Therapeutics